🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multiple sclerosis is the most common inflammatory disease of the central n...
Status
Terminated
Location
Johns Hopkins University
Start Date
2021-10-01
Trial ID
NCT04767698
Treatments Being Tested
This is a Phase IIIb, single-arm, multicenter, OLE study. Participants rece...
Status
Active Not Recruiting
Location
Barrow Neurological Institute
Start Date
2022-05-03
Trial ID
NCT05269004
Treatments Being Tested
The main purpose of this study is to evaluate the safety and tolerability o...
Status
Active Not Recruiting
Location
Profound Research, LLC
Start Date
2024-12-17
Trial ID
NCT07667322
Treatments Being Tested
The proposed study is a pilot study of ublituximab involving people with mu...
Status
Recruiting
Location
Johns Hopkins University
Start Date
2026-02-10
Trial ID
NCT07389590
Treatments Being Tested
This is a multicentre observational study with the aim of evaluating the an...
Status
Completed
Location
IRCCS Istituto Tumori Giovanni Paolo II
Start Date
2021-04-19
Trial ID
NCT04848493
Treatments Being Tested
This is a randomized, double blind, controlled, parallel group, multicenter...
Status
Active Not Recruiting
Location
Alabama Neurology Associates
Start Date
2020-12-03
Trial ID
NCT04548999
Treatments Being Tested
This study is a prospective, multi-center, randomized, double blinded, plac...
Status
Recruiting
Location
Yale School of Medicine
Start Date
2023-02-07
Trial ID
NCT05285891
Treatments Being Tested
The study will evaluate the physical impact of MS from participant's perspe...
Status
Recruiting
Location
CHU Amiens Hopital Sud
Start Date
2024-12-13
Trial ID
NCT06675955
Treatments Being Tested
This study will evaluate the efficacy and safety of ocrelizumab, compared w...
Status
Terminated
Location
Multiple Locations
Start Date
2007-06-11
Trial ID
NCT00485589
Treatments Being Tested
This study seeks to assess the effects of long-term ocrelizumab therapy on ...
Status
Not Yet Recruiting
Location
John D. Dingell VA Medical Center
Start Date
2025-09-30
Trial ID
NCT07181811